Sharp – a leader in pharmaceutical contract packaging, clinical trial supply services and small-scale sterile manufacturing – is delighted today to announce that it has joined the United Nations Global Compact initiative — a voluntary initiative for the development, implementation and disclosure of responsible business practices.
With this announcement Sharp is proud to join hundreds of other companies globally in the pharmaceutical sector who have committed to taking responsible business action to help create a better world for everyone.
Speaking about the announcement, Kevin Orfan, Sharp’s President & CEO said “Sharp’s membership of the UN Global Compact is clear evidence of our commitment to responsible corporate governance and demonstrates our intention to put our stakeholders’ interests’ at the heart of our decision making”
The UN Global Compact is a call to companies to align their operations and strategies with ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption, and to act in support of Sustainable Development Goals.
Sharp will focus initially on actions that align with stakeholder priorities, as identified through a double materiality process conducted earlier this year. Those areas include sustainable procurement, environmental sustainability, labor and human rights and anti-corruption, providing a natural alignment with the 10 Principles of the UN Global Compact.
“This is a further milestone in our development as a sustainable organisation”, commented Hywel Woolf, Global Sustainability Manager at Sharp. “The UN Global Compact is a global framework for action that brings structure and transparency to sustainability, that will help us to progress and report on our environmental, social and governance ambitions. The requirement to Communicate on Progress provides Sharp with the framework to align our own ESG strategy whilst continuing our transparent progression as a sustainable organisation.”
Launched in 2000, the UN Global Compact is the largest corporate sustainability initiative in the world, with more than 20,000 companies based in over 160 countries, and more than 60 Global Compact Networks.
As a member of the UN Global Compact, Sharp has committed to providing regular updates on its progress through the publication of a Communication of Progress (COP) report which will be published annually. Visit the Sharp profile on the UN Global Compact website to learn more.
About Sharp
Sharp is a leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing, with a heritage spanning more than 70 years. We partner with pharmaceutical and biotechnology clients, offering solutions and support from phase I trials all the way through to commercial launch and lifecycle management. Together, our 2,500+ strong team leverage the capabilities in state-of-the-art GMP facilities in the US, UK, Belgium, and the Netherlands. For more information on Sharp and its solutions, visit www.sharpservices.com or follow us on LinkedIn.
For further information, images and interview opportunities, please contact Alison Dillon, Global Director, Strategic Marketing and Communications at Sharp:
